A multicenter phase II trial with gemcitabine plus oxaliplatin as second line treatment in patients with advanced non-small cell lung cancer (NSCLC)
2004 ◽
Vol 22
(14_suppl)
◽
pp. 7263-7263
Keyword(s):
Phase Ii
◽